| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/11/2002 | EP1165122B1 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 09/11/2002 | EP1100463B1 New injectable formulations containing ramoplanin |
| 09/11/2002 | EP1073444A4 A food composition and method of using same |
| 09/11/2002 | EP1054892B1 Azole peptidomimetics as thrombin receptor antagonists |
| 09/11/2002 | EP1003539A4 FLUORESCENT AMYLOID A beta PEPTIDES AND USES THEREOF |
| 09/11/2002 | EP0989854A4 Compositions useful as fibrin sealants |
| 09/11/2002 | EP0954527A4 Glycine transporter-transfected cells and uses thereof |
| 09/11/2002 | EP0910399B1 Stable pharmaceutical composition of bdnf |
| 09/11/2002 | EP0871467B1 Formulation for peptide release |
| 09/11/2002 | EP0853484B1 Novel mu opioid receptor ligands: agonists and antagonists |
| 09/11/2002 | EP0832098B1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 09/11/2002 | EP0808169A4 Programmed cell death genes and proteins |
| 09/11/2002 | EP0769942B1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/11/2002 | EP0762870B1 Virosome-mediated intracellular delivery of therapeutic agents |
| 09/11/2002 | EP0759776B1 Use of igf-i or analogues thereof in the prevention of diabetes |
| 09/11/2002 | EP0603399B1 Endothelin-antagonizing peptide |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
| 09/11/2002 | CN1368978A Novel proteins and uses thereof |
| 09/11/2002 | CN1368899A Preparation of therapeutic composition |
| 09/11/2002 | CN1368892A Sustained release formulation of peptide |
| 09/11/2002 | CN1368887A Mycophenolate Mofetil in association with PEG-IFN alpha |
| 09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
| 09/11/2002 | CN1368879A Use of (-)(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/11/2002 | CN1368877A Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same |
| 09/11/2002 | CN1368875A Supercritical fluid-assisted nebulization and bubble drying |
| 09/11/2002 | CN1368874A Implantable active ingredient depot |
| 09/11/2002 | CN1368511A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368510A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368509A Human protein with suppression to cancer cell growth and its coding sequence |
| 09/11/2002 | CN1368508A Human protein with cancer inhibiting function and its coding sequence |
| 09/11/2002 | CN1368383A Precision and preparing process of health-care compound hormone product |
| 09/11/2002 | CN1368382A Usage of hypophloeodal colyone and its application |
| 09/11/2002 | CN1368381A Liquid T cell factor preparation |
| 09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
| 09/11/2002 | CN1090508C Storage stable water solution for infusion containing thrombin inhibitor |
| 09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 09/11/2002 | CN1090506C Application of lysozyme dimer |
| 09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
| 09/10/2002 | US6448468 Transgenetic mouse which comprises an inactive Peg3 gene, and the use thereof |
| 09/10/2002 | US6448382 Loading a mixture of isoforms onto a tsk sulfopropyl cation exchange chromatography column, washing with linear gradient buffer, discarding fraction comprising double clipped isoform and collecting intact and single-clipped isoforms |
| 09/10/2002 | US6448380 Complexing |
| 09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
| 09/10/2002 | US6448378 Made by preparing a purified solution of monoreactive-amine modified collagen, such as glutaric anhydride derivatized collagen, heating to reduce viscosity and adding the drug to the solution, casting into thin layers, drying into film |
| 09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
| 09/10/2002 | US6448375 Active and inactive CC-chemokine receptor |
| 09/10/2002 | US6448374 Production of phosphopeptides from casein |
| 09/10/2002 | US6448292 Comprising a diglyceride in which at least 55% by weight of constitutive acyl groups are unsaturated acyl groups and 15 to 100% by weight thereof are omega 3 type unsaturated acyl groups having at least 20 carbon atoms and a triglyceride |
| 09/10/2002 | US6448278 Antiscarring agent |
| 09/10/2002 | US6448263 Synthesis routes for such as 2-amino-n-(2-(3a-(r)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c) pyridin-5-yl)-1-(r)-benzyloxymethyl-2-oxo-ethyl)-isobutyramide l-tartaric acid salt |
| 09/10/2002 | US6448234 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/10/2002 | US6448231 Presynaptic neurotoxin such as botulinum toxin a |
| 09/10/2002 | US6448230 Testis expressed polypeptide |
| 09/10/2002 | US6448229 Gamma secretase inhibitors |
| 09/10/2002 | US6448227 Therapeutically effective substance mixture |
| 09/10/2002 | US6448225 Human growth hormone aqueous formulation |
| 09/10/2002 | US6448224 Antibiotics and methods of using the same |
| 09/10/2002 | US6448223 Antagonists of HMG1 for treating inflammatory conditions |
| 09/10/2002 | US6448222 Antitumor agent; antimetastasis agent |
| 09/10/2002 | US6448221 By administering an adipocyte complement related protein to reduce platelet aggregation |
| 09/10/2002 | US6448093 Solubilization of hyaluronic acid in aqueous solution of electrolyte and acid; solubilization of polar substancec (i.e. a plasmid) in mixture; acidification; dialyzing said mixture to reduce an ionic concentration past point of collapse |
| 09/10/2002 | US6448081 Oligonucleotides specifically hybridizable with nucleic acids encoding interleukin 12 p40 subunit |
| 09/10/2002 | US6448080 Antisense modulation of WRN expression |
| 09/10/2002 | US6448079 Inhibiting the expression of p38 mitogen activated protein kinase in cells or tissues comprising contacting said cells or tissues in vitro with the antisense compound |
| 09/10/2002 | US6448078 Inhibiting human vpr interacting protein activity in a cell using a nucletide sequence complementary to a portion of the nucleotide sequence that encodes hvip; anticancer agent |
| 09/10/2002 | US6448077 Chimeric and humanized monoclonal antibodies specific to VEGF receptors |
| 09/10/2002 | US6448072 Human transcription factor iia (tfiia) is a cellular factor that, together with additional protein components, regulates the expression of human genes |
| 09/10/2002 | US6448071 Effective competitors to t cell receptors and mhc molecules normally involved in transplant rejection and autoimmune disease |
| 09/10/2002 | US6448059 Methods and composition for inhibition of tRNA activities |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | US6448044 DNA encoding human natural killer cell activating factor II |
| 09/10/2002 | US6448042 These enzymes have been implicated in a variety of disease processes, including tumor cell invasion, tumor angiogenesis and rheumatoid arthritis |
| 09/10/2002 | US6448041 Colon cancer marker |
| 09/10/2002 | US6448040 Nucleic acid molecules encoding hypusine mutants having the biological activity, of inhibiting cellular proliferation |
| 09/10/2002 | US6448038 BirA from staphylococcus aureus |
| 09/10/2002 | US6448037 PgsA |
| 09/10/2002 | US6448036 ribB |
| 09/10/2002 | US6448035 Disorders mediated by disease states associated with suppressed immune function can be treated by administering a soluble form of the negative signaling lir |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448022 Method for evaluating inhibition of human chorionic gonadotropin (hcg) production of a subject's trophoblast cells comprising the steps of isolating a regulatory polypeptide inhibits, in a dose dependent manner, the production of hcg by |
| 09/10/2002 | US6448020 Molecules associated with the human suppressor of fused gene |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6448009 Method for target site selection and discovery |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447996 Polypeptides having galanin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed. |
| 09/10/2002 | US6447808 Pharmaceutical or veterinary composition for treating wounds comprising milk product extracts including growth factors with basic to neutral isoelectric points |
| 09/10/2002 | US6447806 Water insoluble cyclosporin colloids having charged phosphatides on the surface as stabilizers; drug delivery |
| 09/10/2002 | US6447796 Sustained release hydrophobic bioactive PLGA microspheres |
| 09/10/2002 | US6447787 Methods for enhancing wound healing |
| 09/10/2002 | US6447786 Cyclic oligopeptides used as controllers of rna transcription factors in staphylococcus grampositive bacteria; prevention of infections |
| 09/10/2002 | US6447785 Method for treating hypercalcemia |
| 09/10/2002 | US6447784 Genetically engineered salmonella for use in the treatment of cancer |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447781 Administering protein complexes including antigens to humans for prevention of adenocarcinomas, melanomas, neuroblastomas, leukemia, lymphomas and mylomas; immunology; vaccines |
| 09/10/2002 | US6447780 Administering heat shock proteins (hsp) complexed with antigens; antigrowth agents or development inhibitors for cancer; immunology; vaccines |
| 09/10/2002 | US6447777 Polymerized staphylococcal protein a for treatment of diseases |
| 09/10/2002 | US6447776 Monoclonal antibodies against mutant amino acid sequences generated by genetic deletions or point mutations; detection of cancer |
| 09/10/2002 | US6447775 Prevention of endocytosis and metabolism of amyloid precursor proteins by blocking the binding to low density lipoprotein receptors (lrp); antigens |